- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Jos Jonkers
Netherlands Cancer Institute, Amsterdam, Netherlands
- Permission not
granted for presentation
EGFR and HER2: Network signaling and next-generation drugs
Yosef Yarden
Weizmann Institute of Science, Rehovot, Israel
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Ann Mullally
Brigham & Women's Hospital, Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Todd R. Golub
Broad Inst. of MIT and Harvard, Cambridge, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
James V. Lacey
City of Hope, Duarte, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Speaker
Darrin D. Stuart
Novartis, Marblehead, MA, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Akinyemi Ojesina
University of Alabama at Birmingham, Birmingham, AL, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Dario C. Altieri
The Wistar Inst., Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Steven Piantadosi
Cedars-Sinai Medical Ctr., Los Angeles, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Michael S. Lawrence
Broad Institute of Harvard and MIT, Cambridge, MA, United States
- Permission not
granted for presentation
Invited Speaker
Dung T. Le
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Robert H. Shoemaker
National Cancer Institute, Division of Cancer Prevention, Bethesda, MD, United States
- Free
- slides video
- audio + slides
- All slides included
G-quadruplexes and DNA dynamics
Shankar Balasubramanian
University of Cambridge, Cambridge, United Kingdom
- Free
- podium video
- audio + slides
- Some slides withheld
Activity-based biomarkers for noninvasive cancer detection
Sangeeta N. Bhatia
Massachusetts Institute of Technology, Cambridge, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Novel approaches for personalizing treatments: From nutrition to cancer
Eran Segal
Weizman Institute of Science, Rehovot Israel, Israel
- Free
- Unknown permission
for presentation
Mathematical modeling of cancer evolution
Franziska Michor
Dana-Farber Cancer Institute, Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Molecular subgrouping of bladder cancer, tumor clonality, and ctDNA follow-up in the clinic
Torben F. Orntoft
Aarhus University Hospital (Skejby), Aarhus N, Denmark
- Free
- slides video
- audio + slides
- All slides included
Genomic dissection of the clonal evolution dynamics of chemotherapy-resistant urothelial carcinoma
Bishoy M Faltas
Weill Cornell Medicine, New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Bladder cancer heterogeneity: Drivers or progenitor cells?
Xue-Ru Wu
Nyu Sch. Of Med./Va Med. Ctr., New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Diagnostic and prognostic markers for patient management
Ellen C. Zwarthoff
Erasmus Medical Ctr., Rotterdam, Netherlands
- Free
- slides video
- audio + slides
- All slides included
Beyond the exome: Noncoding alterations in cancer genomes
Matthew L. Meyerson
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Identification of novel modulators of response to immune checkpoint blockade in lung cancer patients through the marrying of clinical and genomic data
Phil Stephens
Foundation Medicine, Inc., Cambridge, MA, United States
- Permission not
granted for presentation
The application of integrative sequencing for precision oncology
Arul M. Chinnaiyan
Univ. of Michigan, Ann Arbor, MI, United States
- Free
- slides video
- audio + slides
- All slides included
Engineering next-generation CAR T cells using synthetic biology-inspired technologies
Michael C Jensen
Seattle Children's Hospital, Seattle, WA, United States
- Free
- slides video
- audio + slides
- All slides included
Defining the limitations of CD19CAR immunotherapy in pediatric ALL and development of effective countermeasures
Terry J Fry
National Cancer Institute, Bethesda, MD, United States